Curevo

About:

Curevo is a clinical-stage biotech firm that focuses on producing vaccines.

Website: http://www.curevovaccine.com

Top Investors: RA Capital Management, Janus Henderson Investors, Adjuvant Capital, E&Investment, Green Cross Holding

Description:

Curevo is a clinical-stage biotech firm focused on producing vaccines that brings effectiveness, safety, tolerability, and advanced production capabilities to the market. Curevo's lead product, a sub-unit Zoster (Shingles) Vaccine, has completed Phase I (90-subject trial). Results are showing a promising safety profile and the desired immune responses. They are targeting a unique position in the $7B Varicella Zoster Virus vaccine market.